Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Choosing between Sp500 and Total Market funds can shape your retirement. This guide compares performance, diversification, and allocation to help you decide.
28,514 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Vuzix is aiming to turn AR glasses into practical frontline tools. This guide breaks down what vuzix (vuzi) 2026 earn...
Lenders and buyers increasingly trust AI-driven recommendations to steer them toward agents. This report shows how to...
Polestar faces a pivotal period as it refines profitability and expansion amid a crowded EV field. This report outlin...
A widening disconnect between executive teams and frontline operations is dragging down loan-technology upgrades. The...
California's new EV incentive is tilting the playing field for Rivian and Tesla. With Q1 results out, investors are w...
SoundHound AI is testing a high-growth path in voice commerce and Vision AI. This article explains why some investors...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
Microsoft stock has slipped in 2026, but a strong earnings report could ignite a rebound. This guide breaks down what...
Quantum hype is everywhere, but one cloud leader is turning theory into revenue today. This article explains how they...
Jaguar Health faces a pivotal year as its key drug Mytesi and pipeline shape 2025 outcomes. This guide breaks down Q3...
Intel stunned investors with a triple-digit rally in early 2026. This guide breaks down why intel stock soared 278%, ...